Literature DB >> 28890187

Kinetic analysis of the inhibition of the drug efflux protein AcrB using surface plasmon resonance.

Rumana Mowla1, Yinhu Wang2, Shutao Ma2, Henrietta Venter3.   

Abstract

Multidrug efflux protein complexes such as AcrAB-TolC from Escherichia coli are paramount in multidrug resistance in Gram-negative bacteria and are also implicated in other processes such as virulence and biofilm formation. Hence efflux pump inhibition, as a means to reverse antimicrobial resistance in clinically relevant pathogens, has gained increased momentum over the past two decades. Significant advances in the structural and functional analysis of AcrB have informed the selection of efflux pump inhibitors (EPIs). However, an accurate method to determine the kinetics of efflux pump inhibition was lacking. In this study we standardised and optimised surface plasmon resonance (SPR) to probe the binding kinetics of substrates and inhibitors to AcrB. The SPR method was also combined with a fluorescence drug binding method by which affinity of two fluorescent AcrB substrates were determined using the same conditions and controls as for SPR. Comparison of the results from the fluorescent assay to those of the SPR assay showed excellent correlation and provided validation for the methods and conditions used for SPR. The kinetic parameters of substrate (doxorubicin, novobiocin and minocycline) binding to AcrB were subsequently determined. Lastly, the kinetics of inhibition of AcrB were probed for two established inhibitors (phenylalanine arginyl β-naphthylamide and 1-1-naphthylmethyl-piperazine) and three novel EPIs: 4-isobutoxy-2-naphthamide (A2), 4-isopentyloxy-2-naphthamide (A3) and 4-benzyloxy-2-naphthamide (A9) have also been probed. The kinetic data obtained could be correlated with inhibitor efficacy and mechanism of action. This study is the first step in the quantitative analysis of the kinetics of inhibition of the clinically important RND-class of multidrug efflux pumps and will allow the design of improved and more potent inhibitors of drug efflux pumps. This article is part of a Special Issue entitled: Beyond the Structure-Function Horizon of Membrane Proteins edited by Ute Hellmich, Rupak Doshi and Benjamin McIlwain.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AcrB; Affinity constant; Drug efflux; Efflux pump inhibitor; Multidrug resistance; Surface plasmon resonance

Mesh:

Substances:

Year:  2017        PMID: 28890187     DOI: 10.1016/j.bbamem.2017.08.024

Source DB:  PubMed          Journal:  Biochim Biophys Acta Biomembr        ISSN: 0005-2736            Impact factor:   3.747


  6 in total

Review 1.  The hydrophobic trap-the Achilles heel of RND efflux pumps.

Authors:  Zachary Aron; Timothy J Opperman
Journal:  Res Microbiol       Date:  2017-11-13       Impact factor: 3.992

2.  Structure, Assembly, and Function of Tripartite Efflux and Type 1 Secretion Systems in Gram-Negative Bacteria.

Authors:  Ilyas Alav; Jessica Kobylka; Miriam S Kuth; Klaas M Pos; Martin Picard; Jessica M A Blair; Vassiliy N Bavro
Journal:  Chem Rev       Date:  2021-04-28       Impact factor: 60.622

3.  Mechanistic Duality of Bacterial Efflux Substrates and Inhibitors: Example of Simple Substituted Cinnamoyl and Naphthyl Amides.

Authors:  Napoleon D'Cunha; Mohammad Moniruzzaman; Keith Haynes; Giuliano Malloci; Connor J Cooper; Enrico Margiotta; Attilio V Vargiu; Muhammad R Uddin; Inga V Leus; Feng Cao; Jerry M Parks; Valentin V Rybenkov; Paolo Ruggerone; Helen I Zgurskaya; John K Walker
Journal:  ACS Infect Dis       Date:  2021-08-11       Impact factor: 5.578

4.  Surface plasmon resonance analysis for detecting non-structural protein 1 of dengue virus in Indonesia.

Authors:  Agus Sjahrurachman; Beti Ernawati Dewi; Kenny Lischer; Diah Kartika Pratami; Darin Flamandita; Muhamad Sahlan
Journal:  Saudi J Biol Sci       Date:  2020-06-17       Impact factor: 4.219

5.  Reversing resistance to counter antimicrobial resistance in the World Health Organisation's critical priority of most dangerous pathogens.

Authors:  Henrietta Venter
Journal:  Biosci Rep       Date:  2019-04-12       Impact factor: 3.840

6.  Perturbed structural dynamics underlie inhibition and altered efflux of the multidrug resistance pump AcrB.

Authors:  Eamonn Reading; Zainab Ahdash; Chiara Fais; Vito Ricci; Xuan Wang-Kan; Elizabeth Grimsey; Jack Stone; Giuliano Malloci; Andy M Lau; Heather Findlay; Albert Konijnenberg; Paula J Booth; Paolo Ruggerone; Attilio V Vargiu; Laura J V Piddock; Argyris Politis
Journal:  Nat Commun       Date:  2020-11-04       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.